VHOSPITAL.CLINIC · Medical Condition
Pulmonary Fibrosis: Overview, Symptoms, Causes and Treatment
Pulmonary fibrosis is progressive scarring of lung tissue, causing worsening breathlessness, dry cough, and reduced exercise tolerance. Idiopathic pulmonary fibrosis (IPF) has a median survival of 3-5 years; antifibrotic drugs slow progression.
Explore Pulmonary Fibrosis
Common Symptoms of Pulmonary Fibrosis
Medical Questions About Pulmonary Fibrosis
Clinical Insights
Clinical Overview
High-level clinical summary, typical presentation and rule-out logic for Pulmonary Fibrosis
Treatment & Management
Evidence-based treatment pathway, medications, monitoring & escalation for Pulmonary Fibrosis
Complications & Risks
Early, long-term, and emergency complications of Pulmonary Fibrosis
Prognosis & Outlook
Long-term clinical outlook, improving/worsening factors, and monitoring for Pulmonary Fibrosis
Differential Diagnosis
Conditions that mimic Pulmonary Fibrosis — key distinguishing features & tests
Clinical Comparisons
Pulmonary Fibrosis is frequently confused with these conditions — see head-to-head comparisons for distinguishing tests and treatment differences.
Clinical Q&A
Medical References
Content on this page is informed by evidence-based clinical sources including:
- World Health Organization (WHO)Global health guidance and disease classification
- National Health Service (NHS)UK clinical guidelines and patient information
- National Institute for Health and Care Excellence (NICE)Evidence-based clinical practice guidelines
- Centers for Disease Control and Prevention (CDC)US public health data and clinical recommendations
- PubMed – NCBIPeer-reviewed biomedical literature and clinical studies
- Cochrane LibrarySystematic reviews and meta-analyses in evidence-based medicine
Concerned about Pulmonary Fibrosis?
Describe your symptoms and get a structured clinical assessment — possible causes, red flags, and recommended next steps.
Start Free AI Analysis →